- Home
- DNTH vs HKD Comparison
DNTH vs HKD Comparison
Compare DNTH & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- HKD
- Stock Information
- Founded
- DNTH 2015
- HKD 2003
- Country
- DNTH United States
- HKD France
- Employees
- DNTH N/A
- HKD N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- HKD Finance: Consumer Services
- Sector
- DNTH Health Care
- HKD Finance
- Exchange
- DNTH Nasdaq
- HKD Nasdaq
- Market Cap
- DNTH 606.2M
- HKD 656.8M
- IPO Year
- DNTH N/A
- HKD 2022
- Fundamental
- Price
- DNTH $21.50
- HKD $1.84
- Analyst Decision
- DNTH Strong Buy
- HKD
- Analyst Count
- DNTH 8
- HKD 0
- Target Price
- DNTH $53.00
- HKD N/A
- AVG Volume (30 Days)
- DNTH 387.8K
- HKD 228.8K
- Earning Date
- DNTH 08-07-2025
- HKD 01-01-0001
- Dividend Yield
- DNTH N/A
- HKD N/A
- EPS Growth
- DNTH N/A
- HKD 9.93
- EPS
- DNTH N/A
- HKD 0.23
- Revenue
- DNTH $6,524,000.00
- HKD $20,445,000.00
- Revenue This Year
- DNTH N/A
- HKD N/A
- Revenue Next Year
- DNTH N/A
- HKD N/A
- P/E Ratio
- DNTH N/A
- HKD $8.03
- Revenue Growth
- DNTH 102.36
- HKD N/A
- 52 Week Low
- DNTH $13.37
- HKD $1.65
- 52 Week High
- DNTH $32.27
- HKD $5.80
- Technical
- Relative Strength Index (RSI)
- DNTH 61.73
- HKD 50.19
- Support Level
- DNTH $19.90
- HKD $1.77
- Resistance Level
- DNTH $22.49
- HKD $1.84
- Average True Range (ATR)
- DNTH 1.43
- HKD 0.07
- MACD
- DNTH 0.22
- HKD 0.02
- Stochastic Oscillator
- DNTH 64.11
- HKD 70.59
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.